EcoR1 Capital is a biotech-focused investment advisory firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | Yes |
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | Yes |
Sep 14, 2020
Neogene Therapeutics
|
Series A | $110M | Biotechnology | Yes |
Aug 26, 2020
Freenome
|
Series C | $270M | Biotechnology | — |